Prp19/CDC5L is implicated in cell cycle regulation, mitotic checkpoint control, and DNA repair 7-10, linking it to cancer pathogenesis, as evidenced in non-small cell lung cancer, hepatocellular carcinoma, and colorectal cancer 11-14. This evidence concerns the gene CDC5L and cancer.